Annovis Bio Receives NYSE Non-Compliance Notice Due to Low Market Capitalization
Annovis Bio (ANVS) announced on Friday that it has received a formal notice from the New York Stock Exchange regarding its failure to meet continued listing standards. The notification stems from the company's market capitalization falling below the required threshold. As of October 28, 2026, Annovis Bio's 30-trading-day average market capitalization was approximately $48.4 million. This regulatory notice places the company at risk of delisting if it cannot rectify its compliance status within the specified timeframe.